Literature DB >> 22722328

Validation of online calculators to predict the non-sentinel lymph node status in sentinel lymph node-positive breast cancer patients.

Satoru Tanaka1, Nayuko Sato, Hiroya Fujioka, Yuko Takahashi, Kosei Kimura, Mitsuhiko Iwamoto.   

Abstract

PURPOSE: This study evaluated and compared the predictive values of the Memorial Sloan-Kettering Cancer Center (MSKCC) nomogram and the Stanford nomogram for predicting non-sentinel lymph node (SLN) metastasis in patients with SLN metastasis, which were the only nomograms available online, and verified their usefulness in the macrometastasis or micrometastasis/isolated tumor cell (ITC) subgroups.
METHODS: Eighty-nine patients with a positive SLN biopsy who underwent axillary lymph node dissection were analyzed. The predicted probability of non-SLN metastasis was calculated using a computerized model from the websites for each nomogram. The results were compared using the area under the curve (AUC) of the receiver operating characteristics curve for each model. The false-negative and false-positive rates were also calculated.
RESULTS: The AUC for the entire population was 0.701 with the MSKCC nomogram and 0.756 with the Stanford nomogram. The AUCs of macrometastasis and micrometastasis/ITC groups were 0.680 and 0.469 with the MSKCC nomogram, and were 0.676 and 0.574 with the Stanford nomogram, respectively. Although false-negative cases were not identified, the false-positive rates were high in both subgroups when using these nomograms.
CONCLUSIONS: This independent comparison found no significant difference between the two nomograms. In this study, these nomograms could not reliably predict positive non-SLN in patients with SLN micrometastasis/ITC.

Entities:  

Mesh:

Year:  2012        PMID: 22722328     DOI: 10.1007/s00595-012-0229-2

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  29 in total

Review 1.  Clinical role of sentinel-lymph-node biopsy in breast cancer.

Authors:  Mohammed R S Keshtgar; Peter J Ell
Journal:  Lancet Oncol       Date:  2002-02       Impact factor: 41.316

2.  Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes.

Authors:  James W Jakub; Nils M Diaz; Mark D Ebert; Alan Cantor; Douglas S Reintgen; Elisabeth L Dupont; Alan R Shons; Charles E Cox
Journal:  Am J Surg       Date:  2002-10       Impact factor: 2.565

3.  Sentinel node micrometastasis in breast carcinoma may not be an indication for complete axillary dissection.

Authors:  Heather Rutledge; Joseph Davis; Ronald Chiu; Michael Cibull; Yolanda Brill; Patrick McGrath; Luis Samayoa
Journal:  Mod Pathol       Date:  2005-06       Impact factor: 7.842

4.  Sentinel lymphadenectomy in breast cancer.

Authors:  A E Giuliano; R C Jones; M Brennan; R Statman
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

5.  Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?

Authors:  K U Chu; R R Turner; N M Hansen; M B Brennan; A Bilchik; A E Giuliano
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

6.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

7.  Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?

Authors:  C Reynolds; R Mick; J H Donohue; C S Grant; D R Farley; L S Callans; S G Orel; G L Keeney; T J Lawton; B J Czerniecki
Journal:  J Clin Oncol       Date:  1999-06       Impact factor: 44.544

8.  Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms.

Authors:  Giovanni D'Eredità; Vito Leopoldo Troilo; Carmela Giardina; Anna Napoli; Giuseppe Rubini; Fernando Fischetti; Tommaso Berardi
Journal:  Clin Breast Cancer       Date:  2010-12-01       Impact factor: 3.225

9.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.

Authors:  Armando E Giuliano; Kelly K Hunt; Karla V Ballman; Peter D Beitsch; Pat W Whitworth; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Linda M McCall; Monica Morrow
Journal:  JAMA       Date:  2011-02-09       Impact factor: 56.272

10.  Assessment of the performance of the Stanford Online Calculator for the prediction of nonsentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients.

Authors:  Jeffrey S Scow; Amy C Degnim; Tanya L Hoskin; Carol Reynolds; Judy C Boughey
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

View more
  3 in total

1.  Outcome of sentinel lymph node biopsy in breast cancer using dye alone: a single center review with a median follow-up of 5 years.

Authors:  Yoshinari Ogawa; Katsumi Ikeda; Kana Ogisawa; Shinya Tokunaga; Hiroko Fukushima; Takeshi Inoue; Yoshihiro Mori; Akiko Tachimori; Toru Inoue; Yukio Nishiguchi
Journal:  Surg Today       Date:  2013-09-26       Impact factor: 2.549

Review 2.  Clinical significance of breast cancer micrometastasis in the sentinel lymph node.

Authors:  Kenzo Shimazu; Shinzaburo Noguchi
Journal:  Surg Today       Date:  2015-04-17       Impact factor: 2.549

3.  Development of a prediction model based on LASSO regression to evaluate the risk of non-sentinel lymph node metastasis in Chinese breast cancer patients with 1-2 positive sentinel lymph nodes.

Authors:  Lei Meng; Ting Zheng; Yuanyuan Wang; Zhao Li; Qi Xiao; Junfeng He; Jinxiang Tan
Journal:  Sci Rep       Date:  2021-10-07       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.